Alzamend Neuro Inc (ALZN) — Cash Flow-to-Debt Ratio
Alzamend Neuro Inc (ALZN) has a Cash Flow-to-Debt Ratio of -0.93x as of January 2026, meaning its operating cash flow of $-1.74 Million could theoretically repay -1% of its total liabilities ($1.86 Million) in one year. Explore Alzamend Neuro Inc operating cash flow efficiency to assess how effectively this company generates cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Alzamend Neuro Inc Cash Flow-to-Debt Ratio (2016–2025)
Historical debt coverage capacity for Alzamend Neuro Inc across 10 annual periods. Also explore balance sheet size of Alzamend Neuro Inc for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Alzamend Neuro Inc (2016–2025)
Year-by-year debt coverage analysis for Alzamend Neuro Inc. For market capitalisation and broader financial context, see ALZN stock market capitalisation.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -10.35x | $-6.57 Million | $634.76K | ▼ -303.6% |
| 2024 | -2.56x | $-8.27 Million | $3.23 Million | ▲ +17.5% |
| 2023 | -3.11x | $-8.92 Million | $2.87 Million | ▲ +45.2% |
| 2022 | -5.68x | $-6.61 Million | $1.16 Million | ▼ -88.3% |
| 2021 | -3.01x | $-2.71 Million | $899.64K | ▼ -27.5% |
| 2020 | -2.36x | $-2.35 Million | $992.31K | ▼ -167.8% |
| 2019 | -0.88x | $-1.05 Million | $1.18 Million | ▲ +95.8% |
| 2018 | -21.21x | $-2.05 Million | $96.72K | ▼ -973.9% |
| 2017 | -1.98x | $-1.42 Million | $717.22K | ▼ -228.1% |
| 2016 | -0.60x | $-18.49K | $30.72K | — |